Search clinical trials for: Peg-Alpha Interferon

Total 2266 results

University of Bologna
Novartis; Schering-Plough

Terminated

Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)

Chronic Myeloid Leukemia
Foundation for Liver Research

Completed

Long Term Follow-up of Pegylated-Interferon Alpha-2b

Chronic Hepatitis B

Netherlands
Bayside Health
University of Adelaide

Unknown

Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection

Hepatitis C

Australia
Lymphoma Study Association

Completed

Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden

Lymphoma

France, Belgium
University Hospital, Bordeaux
Hoffmann-La Roche; Ministry of Health, France

Completed

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients (ROCO2)

HIV Infections | Hepatitis C, Chronic | Treatment Failure

France
University Hospital, Bordeaux
Hoffmann-La Roche

Completed

Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients (PEGARI)

Hepatitis C, Chronic | HCV Infection

France
French Innovative Leukemia Organisation

Completed

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Leukemia, Lymphocytic, Acute

France
Assuta Hospital Systems
Maccabi Healthcare Services, Israel

Unknown

Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis

Latent Tuberculosis Infection

Israel
University of Turin, Italy
Dimensione Ricerca s.r.l.

Completed

Optimizing IFN Beta - 1B Dose (Optims)

Multiple Sclerosis
Hospices Civils de Lyon

Unknown

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Chronic Myeloid Leukemia

France
University Hospital, Geneva

Completed

Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant

Hepatitis C
French National Agency for Research on AIDS and...
Hoffmann-La Roche

Completed

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

Chronic Hepatitis C

Egypt
University Health Network, Toronto
Hoffmann-La Roche

Terminated

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

HIV Infections | Chronic Hepatitis C

Canada
University of Glasgow
NHS Greater Glasgow and Clyde; Glasgow Western Infirmary

Unknown

A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

Basal Cell Carcinoma

United Kingdom
University of Hamburg-Eppendorf
Hoffmann-La Roche; Universitätsklinikum Hamburg-Eppendorf

Unknown

Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy

Hepatitis C, Chronic | Relapse

Germany
Kirby Institute
The University of New South Wales; Virax Pty. Ltd,

Completed

ITV Extension Study

HIV

Australia
Graceway Pharmaceuticals, LLC

Completed

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

1-Year Follow up to the 1473-IMIQ Study

Keratosis

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C

Chronic Hepatitis C

Egypt
Bnai Zion Medical Center

Unknown

Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.

Chronic Hepatitis C

Israel
Merck Sharp & Dohme LLC

Completed

Upper GI Handling of Branded vs. Generic Alendronate

Osteoporosis
University of Turin, Italy

Unknown

Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance

Insulin Resistance | Chronic Hepatitis C

Italy
Hordinsky, Maria K., MD
3M; National Alopecia Areata Foundation

Completed

Aldara for the Treatment of Extensive Alopecia Areata

Alopecia Areata

United States
Hospital Clinic of Barcelona
Schering-Plough

Completed

Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.

Hepatitis C

Spain
Ain Shams University
National Institute of Allergy and Infectious Diseases (NIAID); Beth Israel... and other collaborators

Completed

Timing and Duration of Acute Hepatitis C Treatment

Hepatitis C

Egypt
Charite University, Berlin, Germany
dfg

Unknown

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Reactive Arthritis

Germany
French National Agency for Research on AIDS and...
Hoffmann-La Roche

Terminated

Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection

HIV Infections | Primary Acute Infection
Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
Foundation for Liver Research
Kyowa Kirin Co., Ltd.

Completed

Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

Chronic Hepatitis C

Netherlands
Dermatologic Cooperative Oncology Group

Unknown

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Therapy | Adjuvant | Stage III Malignant Melanoma | Interferon Alpha

Germany
National Taiwan University Hospital
National Science Council, Taiwan; National Health Research Institutes, Taiwan

Unknown

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta

Chronic Hepatitis B | Chronic Hepatitis D

Taiwan
Royal Marsden NHS Foundation Trust

Completed

A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma

Multiple Myeloma

United Kingdom
University of British Columbia
Vancouver Coastal Health Research Institute; 3M

Completed

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Actinic Keratoses

Canada
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Colon Cancer Stage III

Austria
Clinique de sclérose en plaques et neuromusculaire...

Unknown

Combination Therapy of Betaseron-Prograf in Multiple Sclerosis

Multiple Sclerosis

Canada
Centre Leon Berard
French Immunotherapy Intergroup; SCAPP (Sub-Cutaneous Administration Proleukin...

Completed

Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis

Metastatic Renal Cell Carcinoma

France
National Taiwan University Hospital
Schering-Plough

Completed

Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B

Chronic Hepatitis B
National Cancer Institute, Milan
Associazione Italiana per la Ricerca sul Cancro

Completed

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

Liver Cirrhosis | Hepatocellular Carcinoma | Hepatitis C Virus Infection | Hepatic Resection | Interferon Treatment

Italy
Rennes University Hospital
Wyeth is now a wholly owned subsidiary of Pfizer; Bayer; Farmades, Italy

Terminated

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

France, Italy
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Completed

Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan
The University of Hong Kong

Completed

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

Hepatocellular Carcinoma
University College London Hospitals

Completed

Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication

Chronic Hepatitis C, HCV Genotype 1

United Kingdom
NS Pharma, Inc.

Completed

Study of NS-9 in Patients With Liver Metastases

Neoplasm Metastasis | Liver Neoplasms | Local Neoplasm Recurrences

United States
Hepatitis Resource Network
Integrated Therapeutics Group; Subsidiary of Schering-Plough

Completed

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

HIV Infections | Chronic Hepatitis C Infection in HIV-Infected Persons

United States
Hepatitis Resource Network
Hoffmann-La Roche

Unknown

HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy

HIV Infections | Chronic Hepatitis C Infection in HIV Infected Persons

United States
Hepatitis Resource Network
Hoffmann-La Roche

Completed

PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy

Chronic Hepatitis C Virus Infection

United States
National Taiwan University Hospital

Unknown

Diagnosis of Active Tuberculosis by ELISPOT

Tuberculosis

Taiwan
S. Andrea Hospital

Unknown

Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients

Multiple Sclerosis

Italy
UMC Utrecht

Completed

Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients

Chronic Hepatitis C

Netherlands
Lymphoma Study Association

Completed

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Follicular Lymphoma

France, Belgium

Search clinical trials for: Peg-Alpha Interferon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations